1. Home
  2. BMRN vs AMH Comparison

BMRN vs AMH Comparison

Compare BMRN & AMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • AMH
  • Stock Information
  • Founded
  • BMRN 1996
  • AMH 2012
  • Country
  • BMRN United States
  • AMH United States
  • Employees
  • BMRN N/A
  • AMH N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • AMH Real Estate Investment Trusts
  • Sector
  • BMRN Health Care
  • AMH Real Estate
  • Exchange
  • BMRN Nasdaq
  • AMH Nasdaq
  • Market Cap
  • BMRN 12.1B
  • AMH 14.4B
  • IPO Year
  • BMRN 1999
  • AMH 2013
  • Fundamental
  • Price
  • BMRN $59.01
  • AMH $36.02
  • Analyst Decision
  • BMRN Buy
  • AMH Buy
  • Analyst Count
  • BMRN 23
  • AMH 17
  • Target Price
  • BMRN $93.73
  • AMH $40.85
  • AVG Volume (30 Days)
  • BMRN 1.8M
  • AMH 2.2M
  • Earning Date
  • BMRN 08-04-2025
  • AMH 07-31-2025
  • Dividend Yield
  • BMRN N/A
  • AMH 3.33%
  • EPS Growth
  • BMRN 152.82
  • AMH 10.01
  • EPS
  • BMRN 2.71
  • AMH 1.08
  • Revenue
  • BMRN $2,950,227,000.00
  • AMH $1,764,418,000.00
  • Revenue This Year
  • BMRN $12.27
  • AMH $7.36
  • Revenue Next Year
  • BMRN $9.99
  • AMH $4.85
  • P/E Ratio
  • BMRN $21.81
  • AMH $33.32
  • Revenue Growth
  • BMRN 19.36
  • AMH 6.97
  • 52 Week Low
  • BMRN $52.93
  • AMH $31.68
  • 52 Week High
  • BMRN $94.85
  • AMH $41.41
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 55.66
  • AMH 47.30
  • Support Level
  • BMRN $56.48
  • AMH $36.05
  • Resistance Level
  • BMRN $60.43
  • AMH $36.86
  • Average True Range (ATR)
  • BMRN 1.52
  • AMH 0.49
  • MACD
  • BMRN 0.23
  • AMH 0.10
  • Stochastic Oscillator
  • BMRN 64.05
  • AMH 49.40

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About AMH American Homes 4 Rent of Beneficial Interest

American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.

Share on Social Networks: